Zobrazeno 1 - 10
of 73
pro vyhledávání: '"A. G Obrezan"'
Publikováno v:
КардиоСоматика, Vol 6, Iss 4, Pp 12-16 (2015)
The information content of SCORE model in the evaluation of the total ten-year cardiovascular risk in an isolated sample of 207 males without clinical manifestations of atherosclerosis was investigated. It was revealed that the most of the observatio
Externí odkaz:
https://doaj.org/article/db99da5c85144f4798ed1f0289c60aaa
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 8 (2024)
Aim. To evaluate the association of the triglyceride-glucose index (TGI) with micro- and macrovascular changes in patients with moderate, high and very high cardiovascular risk (CVR).Material and methods. The study included 134 men and 129 women aged
Externí odkaz:
https://doaj.org/article/0cf499ae43f9463a9ab98f88a8a0c30f
Autor:
E. K. Serezhina, A. G. Obrezan
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 3S (2023)
The current classification of heart failure (HF) is based on the myocardium systolic function. However, due to the polyetiological nature of the HF with preserved ejection fraction (HFpEF) and its increasing prevalence and clinical significance, a mo
Externí odkaz:
https://doaj.org/article/79a2d95d209e4bbca317680f3eaa2971
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 66-72 (2022)
This work is devoted to a literature review of published articles, where studies are focused on studying the frequency, structure of complications of cardiovascular diseases in patients with COVID-19, that occurred in vivo and post-mortem: myocarditi
Externí odkaz:
https://doaj.org/article/d9dcfce7bb7043f8b84cb775c2dfdedb
Autor:
M. V. Ezhov, V. V. Kukharchuk, I. V. Sergienko, A. S. Alieva, M. B. Antsiferov, A. A. Ansheles, G. G. Arabidze, D. M. Aronov, G. P. Arutyunov, N. M. Akhmedzhanov, T. V. Balakhonova, O. L. Barbarash, S. A. Boytsov, M. G. Bubnova, M. I. Voevoda, G. R. Galstyan, A. S. Galyavich, N. B. Gornyakova, V. S. Gurevich, I. I. Dedov, O. M. Drapkina, D. V. Duplyakov, S. Ya. Eregin, A. I. Ershova, O. B. Irtyuga, R. S. Karpov, Yu. A. Karpov, M. A. Kachkovsky, Zh. D. Kobalava, N. A. Koziolova, G. A. Konovalov, V. O. Konstantinov, E. D. Kosmacheva, Yu. V. Kotovskaya, A. I. Martynov, A. N. Meshkov, D. V. Nebieridze, S. V. Nedogoda, A. G. Obrezan, V. E. Oleinikov, S. N. Pokrovsky, Yu. I. Ragino, O. P. Rotar, V. V. Skibitsky, O. G. Smolenskaya, A. A. Sokolov, A. B. Sumarokov, E. Filippov, Yu. Sh. Halimov, I. E. Chazova, I. I. Shaposhnik, M. V. Shestakova, S. S. Yakushin, E. V. Shlyakhto
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 5 (2023)
The Russian Society of Cardiology (RKO)With the participation of: The National Society for the Study of Atherosclerosis (NOA), the Russian Association of Endocrinologists (RAE), the Russian Society of Cardiosomatic Rehabilitation and Secondary Preven
Externí odkaz:
https://doaj.org/article/74d801ab1b2e4d4c855890c00ec1b9f6
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 21, Iss 6 (2022)
Improvement of the treatment and diagnosis of hypertension and heart failure (HF) contributes to an increase in life expectancy of the population and, accordingly, its aging. The problem of diagnosing and predicting HF with preserved ejection fractio
Externí odkaz:
https://doaj.org/article/2a51d4c305cf4ad085008cd3635b2893
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 1, Pp 42-48 (2021)
Aim. To study the relationship of modifiable risk factors (RF) with indicators of arterial stiffness and vascular age based on the contour analysis of the pulse wave velocity in hypertensive patients.Material and methods. The material of the study wa
Externí odkaz:
https://doaj.org/article/e33ebc92c8754d98883ba3a563788301
Autor:
V. V. Kukharchuk, M. V. Ezhov, I. V. Sergienko, G. G. Arabidze, T. V. Balakhonova, V. S. Gurevich, P. A. Zelveyan, T. M. Murataliev, G. Sh. Myrzakhmetova, O. A. Sudzhaeva, A. B. Shek, V. A. Azizov, N. B. Gornyakova, M. A. Kachkovsky, P. P. Malyshev, S. N. Pokrovsky, A. A. Sokolov, A. B. Sumarokov, A. G. Obrezan, I. I. Shaposhnik, M. B. Antsiferov, A. A. Ansheles, D. M. Aronov, N. M. Akhmedzhanov, O. L. Barbarash, S. A. Boytsov, M. G. Bubnova, M. I. Voevoda, G. R. Galstyan, A. S. Galyavich, O. M. Drapkina, D. V. Duplyakov, S. Ya. Eregin, R. S. Karpov, Yu. A. Karpov, N. A. Koziolova, G. A. Konovalov, V. O. Konstantinov, E. D. Kosmacheva, S. V. Nedogoda, V. E. Olejnikov, Yu. I. Ragino, V. V. Skibickij, O. G. Smolenskaya, Yu. Sh. Halimov, I. E. Chazova, A. E. Filippov, M. V. Shestakova, S. S. Yakushin
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 6-29 (2020)
Disclaimer РThe EAC/RNAS Guidelines represent the views of the EAC and RNAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC and RNAS is not
Externí odkaz:
https://doaj.org/article/c46699dbb3d34926bc05a10decff3719
Autor:
O. D. Ostroumova, A. I. Kochetkov, F. T. Ageev, G. S. Anikin, E. Kh. Akhmetzyanova, E. I. Bezuglova, A. B. Bekoeva, N. Yu. Borovkova, N. G. Vinogradova, E. V. Gorbunova, A. A. Goryacheva, E. S. Zhugrova, O. A. Kislyak, S. M. Klyashev, V. P. Kuzmin, A. A. Lipchenko, G. V. Matyushin, E. A. Mikhailova, V. A. Nevzorova, A. G. Obrezan, T. A. Petrichko, M. M. Petrova, A. N. Reider, A. N. Repin, V. I. Sadovoy, N. P. Sanina, A. E. Skripchenko, R. I. Stryuk, I. V. Faiyance, L. A. Khaisheva, N. R. Khasanov, R. A. Khokhlov, E. E. Tsareva, A. L. Cherkashina, I. I. Shaposhnik, I. A. Shelestova, R. N. Shepel, E. V. Shikh, D. A. Yakhontov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 2, Pp 175-190 (2020)
Aim. To evaluate the effectiveness and safety of telmisartan, used in monotherapy or in combination with hydrochlorothiazide or amlodipine, in real clinical practice in patients with diagnosed arterial hypertension who have not reached the target lev
Externí odkaz:
https://doaj.org/article/9a89b6f41c844d00b164e671e6fe74c3
A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 5 (2021)
Atrial fibrillation (AF) is a common arrhythmia in patients with type 2 diabetes (T2D). Patients with diabetes are at higher risk of AF than those without it. There is an increased risk of dysglycemia in AF. Patients with AF and concomitant diabetes
Externí odkaz:
https://doaj.org/article/a854fcfa8ca9476d99e750d5d07b98b5